Sullivan Eddie Joe 4
4 · SAB Biotherapeutics, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Sullivan Eddie Joe
DirectorPRESIDENT
Transactions
- Award
Stock Option (right to buy)
2024-07-15+4,447→ 4,447 totalExercise: $2.90Exp: 2034-07-15→ Common Stock (4,447 underlying) - Award
Stock Option (right to buy)
2024-07-15+46,528→ 46,528 totalExercise: $5.40Exp: 2034-07-15→ Common Stock (46,528 underlying)
Footnotes (3)
- [F1]Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option are fully vested.
- [F2]Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028.
- [F3]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.